Caribou cuts pipeline and workforce to focus on lead CAR-T programmes
Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.
Cytiva-Cell & Gene Therapy WP 2
Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data
iECURE gene therapy data suggests partial restoration of functional OTC
Regenxbio’s DMD gene therapy drives 122.3% biomarker uptick in three-year-old
All patients see benefit in Mass Brigham’s cornea stem cell therapy trial
Italian charity seeks EMA approval for rescued gene therapy
First patient dosed in Phase Ib Pompe disease trial
Report finds 70% spike in advanced therapy Phase I trials in UK
